01 3GLAXOSMITHKLINE
01 312396986
01 3Blank
01 3Y
01 32030-11-29
Patent Expiration Date : 2030-11-29
FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US Patent Number : 12396986
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209482
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-11-29
Patent Expiration Date : 2030-11-29
FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US Patent Number : 12396986
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209482
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-11-29
Patent Expiration Date : 2030-11-29
UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US Patent Number : 12396986
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 203975
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-11-29
